97523882 - O VIVANI

Information

• Trademark
• 97523882

• Source

• Serial Number

  97523882

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth

• Filing Date

  July 28, 2022
  2 years ago

• Transaction Date

  May 02, 2025
  a month ago

• Status Date

  May 01, 2025
  a month ago

• Published for Opposition Date

  June 20, 2023
  a year ago

• Location Date

  May 01, 2025
  a month ago

• First Use Anywhere Date

  February 11, 2025
  3 months ago

• First Use In Commerce Date

  February 11, 2025
  3 months ago

• Status Code

  807

• Current Location

  TMO LAW OFFICE 120

  Employee Name

  GRYGIEL, JONATHAN

• Attorney Docket Number

  S-17

  Attorney Name

  Scott B. Dunbar

  Law Office Assigned Location Code

  N20

• Owners

  • Second Sight Medical Products, Inc.

Case File Statements

• DM0000: The mark consists of the wording "Vivani" with an arch of spheres with a stylized O at the top, where the arch of spheres start at the dot of the first "i" in "Vivani" and ends at the dot of the second "i" in "Vivani", all in aqua green.
• GS0051: Implantable drug delivery devices having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; Implantable drug delivery devices having a drug reservoir and a nanoporous membrane sold preloaded with a therapeutic agent, namely, an injectable device for time release of the therapeutic agent for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy
• CC0000: The color(s) aqua green is/are claimed as a feature of the mark.
• GS0011: Nanoporous membranes used in drug delivery devices for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; Nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant
• GS0101: Nanoporous membranes used in drug delivery devices for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy, and other diseases treated with small drug molecules; Electrotherapy medical devices for electrical nerve stimulation and recording, namely, neurostimulation devices, stimulating and recording electrode implants, visual prostheses and visual cortical implants; Cortical electrodes integrally attached to implantable cortical stimulators and other systems, namely, electrodes, stimulators, headpieces, and wearable video processors for the treatment of blindness; Surgical apparatus and instruments for the treatment of blindness; Medical apparatus and instruments for use in surgery for the treatment of blindness; Medical devices for the treatment of blindness

Case File Event Statements

• 8/1/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 8/19/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/20/2022 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 2/13/2023 - 2 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 2/14/2023 - 2 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/14/2023 - 2 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/14/2023 - 2 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/12/2023 - 2 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/12/2023 - 2 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/13/2023 - 2 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/18/2023 - 2 years ago

  11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/18/2023 - 2 years ago

  12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/18/2023 - 2 years ago

  13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/18/2023 - 2 years ago

  14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/18/2023 - 2 years ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/31/2023 - 2 years ago

  16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/20/2023 - a year ago

  17 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/20/2023 - a year ago

  18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/7/2024 - a year ago

  20 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/7/2024 - a year ago

  21 - SOU EXTENSION 1 FILED Type: EXT1

• 8/15/2023 - a year ago

  19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 2/7/2024 - a year ago

  22 - SOU EXTENSION 1 GRANTED Type: EX1G

• 2/9/2024 - a year ago

  23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/14/2024 - 9 months ago

  25 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/21/2024 - a year ago

  24 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 8/15/2024 - 9 months ago

  28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/15/2024 - 9 months ago

  27 - SOU EXTENSION 2 GRANTED Type: EX2G

• 8/15/2024 - 9 months ago

  26 - SOU EXTENSION 2 FILED Type: EXT2

• 2/14/2025 - 3 months ago

  31 - USE AMENDMENT FILED Type: IUAF

• 2/14/2025 - 3 months ago

  29 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 4/30/2025 - a month ago

  32 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 4/30/2025 - a month ago

  30 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 5/1/2025 - a month ago

  33 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT

• 5/1/2025 - a month ago

  34 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/1/2025 - a month ago

  35 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN